Yumi Matsui

456 total citations
21 papers, 342 citations indexed

About

Yumi Matsui is a scholar working on Molecular Biology, Organic Chemistry and Cancer Research. According to data from OpenAlex, Yumi Matsui has authored 21 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Cancer Research. Recurrent topics in Yumi Matsui's work include Peroxisome Proliferator-Activated Receptors (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Drug Transport and Resistance Mechanisms (2 papers). Yumi Matsui is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Drug Transport and Resistance Mechanisms (2 papers). Yumi Matsui collaborates with scholars based in Japan, Germany and Singapore. Yumi Matsui's co-authors include Yoshinobu Takakura, Naoki Kobayashi, Makiya Nishikawa, Makoto Miyagishi, Atsushi Kawase, Kazunari Taira, Kenji Wakabayashi, Kazushi Araki, Yoshihiko Watanabe and Hiroko Kawaguchi and has published in prestigious journals such as New Phytologist, Journal of Pharmacology and Experimental Therapeutics and Pharmaceutical Research.

In The Last Decade

Yumi Matsui

21 papers receiving 335 citations

Peers

Countries citing papers authored by Yumi Matsui

Since Specialization

Citations

This map shows the geographic impact of Yumi Matsui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yumi Matsui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yumi Matsui more than expected).

Fields of papers citing papers by Yumi Matsui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yumi Matsui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yumi Matsui. The network helps show where Yumi Matsui may publish in the future.

Co-authorship network of co-authors of Yumi Matsui

This figure shows the co-authorship network connecting the top 25 collaborators of Yumi Matsui. A scholar is included among the top collaborators of Yumi Matsui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yumi Matsui. Yumi Matsui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of a Novel ATP-Competitive MEK Inhibitor DS03090629 that Overcomes Resistance Conferred by BRAF Overexpression in BRAF-Mutated Melanoma 2023 ·Molecular Cancer Therapeutics ·(unknown), (unknown), (unknown), (unknown), Yoshihiro Shibata, (unknown), (unknown), (unknown), (unknown), Takashi Shimada, (unknown), Yumi Matsui, (unknown), (unknown), (unknown)	3
2	A promiscuous fatty acid ω‐hydroxylase CYP94A90 is likely to be involved in biosynthesis of a floral nitro compound in loquat (Eriobotrya japonica) 2021 ·New Phytologist ·Takuya Yamaguchi, Yumi Matsui, Naoki Kitaoka, Yasumasa KUWAHARA, Yasuhisa Asano, Hideyuki Matsuura, Yukari Sunohara, Hiroshi Matsumoto	12
3	Structure–Activity Relationship Studies of 3- or 4-Pyridine Derivatives of DS-6930 2019 ·ACS Medicinal Chemistry Letters ·(unknown), (unknown), Kunihiko Fujii, (unknown), Yumi Matsui, (unknown), (unknown), Kazushi Araki, (unknown), Nobuaki Watanabe, Makoto Mori, Jun Tanaka	3
4	Discovery of DS-6930, a potent selective PPARγ modulator. Part II: Lead optimization 2018 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Kunihiko Fujii, (unknown), Kousei Shimada, Yoshiyuki Onishi, Yumi Matsui, (unknown), Masanori Kuroha, (unknown), Kazushi Araki, Jun Ohsumi, (unknown), Nobuaki Watanabe, Hideki Yamamoto, Kazunori Fujimoto, (unknown), Makoto Mori, Jun Tanaka	7
5	Discovery of DS-6930, a potent selective PPARγ modulator. Part I: Lead identification 2018 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Kunihiko Fujii, (unknown), Kousei Shimada, Yoshiyuki Onishi, Yumi Matsui, (unknown), Masanori Kuroha, (unknown), Kazushi Araki, Jun Ohsumi, (unknown), Nobuaki Watanabe, Hideki Yamamoto, Kazunori Fujimoto, (unknown), Makoto Mori, Jun Tanaka	11
6	A novel inhibitor stabilizes the inactive conformation of MAPK-interacting kinase 1 2018 ·Acta Crystallographica Section F Structural Biology Communications ·Yumi Matsui, Isao Yasumatsu, Ken Yoshida, Shin Iimura, (unknown), (unknown), (unknown), (unknown), Hiroyuki Hanzawa, (unknown), Takeshi Isoyama	13
7	Discovery and structure-guided fragment-linking of 4-(2,3-dichlorobenzoyl)-1-methyl-pyrrole-2-carboxamide as a pyruvate kinase M2 activator 2017 ·Bioorganic & Medicinal Chemistry ·Yumi Matsui, Isao Yasumatsu, (unknown), Takahiro Kitamura, Kazuo Kanai, (unknown), (unknown), Sachiko Takaishi, Hiroyuki Hanzawa, (unknown)	26
8	Discovery and structure-guided optimization of tert-butyl 6-(phenoxymethyl)-3-(trifluoromethyl)benzoates as liver X receptor agonists 2015 ·Bioorganic & Medicinal Chemistry Letters ·Yumi Matsui, Takahiro Yamaguchi, Takanori Yamazaki, Masayuki Yoshida, Masami Arai, Naoki Terasaka, (unknown), Kenji Wakabayashi, (unknown), Daisuke Nakai, Hiroyuki Hanzawa, Kazuhiko Tamaki	13
9	Synthesis and biological evaluation of novel (−)-cercosporamide derivatives as potent selective PPARγ modulators 2012 ·European Journal of Medicinal Chemistry ·Akihiro Furukawa, Tsuyoshi Arita, Takehiro Fukuzaki, Makoto Mori, Takeshi Honda, Susumu Satoh, Yumi Matsui, Kenji Wakabayashi, (unknown), Kouichi Nakamura, Kazushi Araki, Masanori Kuroha, Jun Tanaka, (unknown), Osamu Suzuki, Jun Ohsumi	13
10	Design and discovery of new (3S,5R)-5-[4-(2-chlorophenyl)-2,2-dimethyl-5-oxopiperazin-1-yl]piperidine-3-carboxamides as potent renin inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·Yutaka Mori, Yasuyuki Ogawa, (unknown), Yuji Nakamura, (unknown), (unknown), Kazuhiko Tamaki, Yumi Matsui, Mizuki Takahashi, Takahiro Nagayama, Yoko Nagai, Shinichi Inoue, Takahide Nishi	9
11	Discovery of DS-8108b, a Novel Orally Bioavailable Renin Inhibitor 2012 ·ACS Medicinal Chemistry Letters ·Yuji Nakamura, Teppei Fujimoto, Yasuyuki Ogawa, (unknown), (unknown), Kazuhiko Tamaki, Mizuki Takahashi, Yumi Matsui, Takahiro Nagayama, Ken-ichi Manabe, Makoto Mizuno, Noriko Masubuchi, Katsuyoshi Chiba, Takahide Nishi	11
12	Substituents at the naphthalene C3 position of (−)-Cercosporamide derivatives significantly affect the maximal efficacy as PPARγ partial agonists 2011 ·Bioorganic & Medicinal Chemistry Letters ·Akihiro Furukawa, Tsuyoshi Arita, Takehiro Fukuzaki, Susumu Satoh, Makoto Mori, Takeshi Honda, Yumi Matsui, Kenji Wakabayashi, (unknown), Kazushi Araki, Jun Ohsumi	16
13	Rh(I)-catalyzed intramolecular [2 + 2 + 1] cycloaddition of allenenes: Construction of bicyclo[4.3.0]nonenones with an angular methyl group and tricyclo[6.4.0.0^1,5]dodecenone 2011 ·Beilstein Journal of Organic Chemistry ·Fuyuhiko Inagaki, (unknown), Yujiro Hayashi, Yumi Matsui, Chisato Mukai	11
14	Pharmacology and in Vitro Profiling of a Novel Peroxisome Proliferator-Activated Receptor .GAMMA. Ligand, Cerco-A 2011 ·Biological and Pharmaceutical Bulletin ·Kenji Wakabayashi, (unknown), Yumi Matsui, (unknown), Akihiro Furukawa, Masanori Kuroha, Naomi Tanaka, (unknown), Shoichi Kanda, Jun Tanaka, Ryo Okuyama, (unknown), (unknown), Kazushi Araki, Jun Ohsumi	16
15	Discovery of a novel selective PPARγ modulator from (−)-Cercosporamide derivatives 2010 ·Bioorganic & Medicinal Chemistry Letters ·Akihiro Furukawa, Tsuyoshi Arita, Susumu Satoh, Kenji Wakabayashi, (unknown), Yumi Matsui, Kazushi Araki, Masanori Kuroha, Jun Ohsumi	16
16	Indoline Derivatives I: Synthesis and Factor Xa (FXa) Inhibitory Activities 2006 ·Chemical and Pharmaceutical Bulletin ·(unknown), Naoki Tanaka, Toyoki Nishimata, (unknown), (unknown), Atsuhiro Sugidachi, Taketoshi Ogawa, Fumitoshi Asai, Yumi Matsui, Koichi Fujimoto	17
17	Sequence-Specific Suppression of mdr1a/1b Expression in Mice via RNA Interference 2005 ·Pharmaceutical Research ·Yumi Matsui, Naoki Kobayashi, Makiya Nishikawa, Yoshinobu Takakura	29
18	Effect of Interferon-γ on the Pharmacokinetics of Digoxin, a P-glycoprotein Substrate, Intravenously Injected into the Mouse 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Hiroko Kawaguchi, Yumi Matsui, Yoshihiko Watanabe, Yoshinobu Takakura	22
19	Vector-Based in Vivo RNA Interference: Dose- and Time-Dependent Suppression of Transgene Expression 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Naoki Kobayashi, Yumi Matsui, Atsushi Kawase, (unknown), Makoto Miyagishi, Kazunari Taira, Makiya Nishikawa, Yoshinobu Takakura	52
20	[Effect of erythromycin on the generation of neutrophil chemiluminescence in vitro]. 1990 ·PubMed ·T. Hirata, S Matsunobe, Yumi Matsui, (unknown), (unknown), S Oshima	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact